drugset

drugset / Trial / NCT02093260

Immunogenocity and Safety of Flubio (Influenza HA) Vaccine in Infants and Children (Bridging Study)

NCT02093260 ↗

Phase 2/3 Completed 405 enrolled PT Bio Farma

NaSingle-groupSingle-blindPrevention

Summary

To Asses the Immunogenicity and Safety of Flubio (Influenza HA) Vaccine in Infants and Children (Bridging Study)

Timeline

Start: 2014-05
Primary completion: 2014-07
Completion: 2014-12

Publications

Soedjatmiko S, Medise BE, Gunardi H, Sekartini R, Satari HI, Hadinegoro SR, Bachtiar NS, Sari RM. Immunogenicity and safety of a Trivalent Influenza HA vaccine in Indonesian infants and children. Vaccine. 2018 Apr 12;36(16):2126-2132. doi: 10.1016/j.vaccine.2018.02.114. Epub 2018 Mar 16.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Influenza Virus Vaccine	Vaccine	—	Intramuscular

Indications

No indication recorded.